Research findings reveal potential to reverse cancer-related nerve pain
A MD Anderson study providing new information about neuropathic pain afflicting some 90 percent of cancer patients who have had nerve damage caused by tumors, surgery, chemotherapy or radiation indicates gene therapy as a possible treatment. Study results were published in Cell Reports. May 05, 2016